期刊文献+

冠脉介入治疗患者造影剂肾病发病率及相关危险因素分析 被引量:4

下载PDF
导出
摘要 目的分析冠脉介入(PCI)治疗造影剂肾病(CIN)的发病率及相关危险因素。方法对2016年1月至2021年11月在我院进行PCI术240例患者开展调查,统计PCI术后CIN的发病率,将患者分为CIN组和非CIN组。采用单因素分析和多因素Logistic回归分析探讨CIN发生的影响因素。结果240例PCI术后患者47例出现CIN,CIN发生率19.58%。经单因素分析,CIN组患者的年龄、高血压病史、造影剂用量、手术时机为择期比例、血清肌酐(Scr)高于非CIN组(P<0.05)。多因素分析,年龄≥70岁、高血压病史、造影剂用量≥200 mL、手术时机为择期、Scr≥140μmol/L为PCI术后并发CIN的独立危险因素。结论CIN在PCI术后有较高的发生率,其中年龄≥70岁、高血压病史、造影剂用量≥200 mL、手术时机为急诊、Scr≥140μmol/L是CIN发生的独立危险因素,应根据这些影响因素制定相应的干预措施,以降低CIN的发生率。
出处 《心血管病防治知识(学术版)》 2022年第26期10-13,共4页 Prevention and Treatment of Cardiovascular Disease
基金 2020年度梅州市社会发展科技计划项目(2020B004)。
  • 相关文献

参考文献14

二级参考文献142

  • 1Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2016, 37 (3) : 267-315. DOI: 10. 1016/j. rec. 2015. 10. 009.
  • 2Nabi F, Chang SM, Xu J, et al. Assessing risk in acute chest pain : The value of stress myocardial perfusion imaging in patients admitted through the emergency department [ J]. J Nucl Cardiol, 2012, 19 (2): 233-243. DOI: 10. 1007/s12350-011-9484-7.
  • 3Shah BN, Balaji G, Alhajiri A, et al. Incremental diagnostic and prognostic value of contemporary stress echocardiography in a chest pain unit: mortality and morbidity outcomes from a real-world setting [J]. Cardiovasc Imaging, 2013, 6 (2): 202-209. DOI: 10. ll61/CIRCIMAGING. 112. 980797.
  • 4Huhen E, Pickett C, Bittencourt MS, et al. Outcomes after coronary computed tomography angiography in theemergency department: a systematic review and meta-analysis of randomized, controlled trials [J]. J Am Coil Cardiol, 2013, 61 (8): 880- 892. DOI: 10. 1016/j. jacc. 2009. 02. 008.
  • 5Mueller C, Giannitsis E, Christ M, et al. Multicenter evaluation of a 0-hour/l-hour algorithm in the diagnosis ofmyocardial infarction with high-sensitivity cardiac troponin T [ J ]. Ann Emerg Med, 2016, pii: S0196-0644 (15) 01501-2. DOI: 10. 1016/j. annemergrned. 2015. 11. 013.
  • 6Reichlin T, Schindler C, Drexler B, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T [J]. Arch Intern Med, 2012, 172 (16) : 1211-1218. DOI: 10. 1001/archintemmed. 2012. 3698.
  • 7Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation [J]. Eur Heart J, 2012, 33 (20) : 2569-2619. DOI: 10. 1093/eurheartj/ehs215.
  • 8Fox KA, Fitzgerald G, Puymirat E, et al. Should patients with acute coronary disease be stratified for management according to their risk Derivation, external validation and outcomes using the updated GRACE risk score [J]. BMJ Open, 2014, 4 (2): e4425. DOI: 10. 1136/bmjopen-2013-O04425.
  • 9Abu-Assi E, Raposeiras-Roubin S, Iear P, et al. Comparing the predictive validity of three contemporary bleeding risk scores in acute coronary syndrome [J]. Eur Heart J Acute Cardiovasc Care, 2012, 1 (3): 222-231. DOI: 10. 1177/2048872612453924.
  • 10Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes [ J ]. N Engl J Med, 2009, 361 (11): 1045-1057. DOI: 10. 1056/ NEJMoa0904327.

共引文献645

同被引文献46

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部